A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

NCT02222480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Fimasartan
DRUG: Hydrochlorothiazide
DRUG: Placebo

Sponsor

Boryung Pharmaceutical Co., Ltd

Collaborators

[object Object]